1. Implications of combined treatment with madopar and L- deprenyl in Parkinson's disease;Birkmayer, W.; Riederer, P.; Ambrozi, L.; Youdim, M.B.H.;Lancet,1977
2. Lees AJ, Shaw KM, Kohout LJ, et al. Deprenyl in Parkinson's disease. Lancet 1977;ii:791-6.
3. Low dosages of bromocriptine added to levodopa in Parkinson's disease;Hoehn, M.M.; Elton, R.L.;Neurology,1985
4. Clinical and biochemical studies with controlled-release levodopa/ carbidopa;Nutt, J.G.; Woodward, W.R.; Carter, J.H.;Neurology,1986
5. Madopar HBS in fluctuating parkinsonian patients: two-year treatment;Pezzoli, G.; Tesei, S.; Ferrante, C.; Cossutta, E.; Scarlato, Zecchinelli A.; G.;Movement Disorders,1988